Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Marinus Pharma CS (MRNS)

11.15   0.45 (4.21%) 09-27 22:30
Open: 11 Pre. Close: 10.7
High: 12.98 Low: 10.84
Volume: 2,323,289 Market Cap: 341M
Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the identification and development of neuropsychiatric therapeutics. The company is headquartered in Radnor, Pennsylvania and currently employs 41 full-time employees. The firm focuses on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders. Its clinical-stage product candidate, ganaxolone, is a modulator being developed in various dose forms, including intravenous, oral capsule and oral liquid, intended to provide more treatment options to adult and pediatric patient populations in both acute and chronic care settings. Ganaxolone acts on the GABAA receptor, a target in the brain known for both anti seizure and anti anxiety effects through positive allosteric modulation. The firm is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19 pediatric epilepsy.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 12.991 - 13.083 13.083 - 13.154
Low: 10.694 - 10.777 10.777 - 10.841
Close: 11.04 - 11.17 11.17 - 11.271

Technical analysis

as of: 2020-09-25 4:32:40 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 15.28     One year: 17.84
Support: Support1: 6.07    Support2: 1.73
Resistance: Resistance1: 13.08    Resistance2: 15.28
Pivot: 4.33
Moving Average: MA(5): 8.04     MA(20): 3.71
MA(100): 2.55     MA(250): 2.09
MACD: MACD(12,26): 1.87     Signal(9): 0.86
Stochastic oscillator: %K(14,3): 84.20     %D(3): 77.39
RSI: RSI(14): 84.50
52-week: High: 13.08  Low: 1.01  Change(%): 624.0
Average Vol(K): 3-Month: 507785  10-Days: 2098384

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
MRNS has closed below upper band by 1.8%. Bollinger Bands are 1147.7% wider than normal. The large width of the bands suggest high volatility as compared to MRNS's normal range. The bands have been in this wide range for 8 bars. This is a sign that the current trend might continue.

Headline News

Fri, 25 Sep 2020
BUZZ-U.S. STOCKS ON THE MOVE-Marinus Pharmaceuticals, Trip.com, Schlumberger, Goldman Sachs - Nasdaq

Tue, 30 Jun 2020
Marinus Pharmaceuticals Provides Pipeline Update Nasdaq:MRNS - GlobeNewswire

Wed, 24 Jun 2020
Marinus Pharmaceuticals to Host Pipeline Update Webinar - GlobeNewswire

Tue, 02 Jun 2020
Marinus Pharmaceuticals Announces Closing of $46 Million Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewswire

Thu, 28 May 2020
Marinus Pharmaceuticals Announces Proposed Public Offering of Common Stock - GlobeNewswire

Mon, 04 May 2020
Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2020 Financial Results - GlobeNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 122
Shares Float (M) 83
% Held by Insiders 0.63
% Held by Institutions 70.29
Shares Short (K) 14,800
Shares Short P. Month (K) 10,670

Stock Financials

EPS -0.968
EPS Est This Year -0.740
EPS Est Next Year -0.560
Book Value (p.s.) 0.760
Profit Margin
Operating Margin
Return on Assets (ttm) -45.5
Return on Equity (ttm) -86.1
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.511
Qtrly Earnings Growth
Operating Cash Flow (M) -58
Levered Free Cash Flow (M) -33

Stock Valuations

PE Ratio -11.52
PEG Ratio
Price to Book value 14.67
Price to Sales
Price to Cash Flow -23.37

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.